What is she best known for?
The fields of study she is best known for:
- Cancer
- Immune system
- Internal medicine
The scientist’s investigation covers issues in Immunology, Cytotoxic T cell, Immunotherapy, Antigen and Transplantation.
Her Immunology research includes themes of Hematopoietic stem cell transplantation and Graft-versus-host disease.
The concepts of her Cytotoxic T cell study are interwoven with issues in Virus, Virology and Immune system.
Catherine M. Bollard has researched Immunotherapy in several fields, including T lymphocyte, Oncology, Viral disease and Nasopharyngeal carcinoma, Nasopharyngeal neoplasm.
The study incorporates disciplines such as Leukemia, Chimeric antigen receptor and IL-2 receptor in addition to Antigen.
The Transplantation study combines topics in areas such as Hematopoietic stem cell, Stem cell, Bone marrow and Cord blood.
Her most cited work include:
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients (738 citations)
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients (738 citations)
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients (585 citations)
What are the main themes of her work throughout her whole career to date?
Catherine M. Bollard mainly investigates Immunology, Cytotoxic T cell, Immunotherapy, Antigen and T cell.
Her Immunology research incorporates elements of Hematopoietic stem cell transplantation, Transplantation and Virology.
Her Transplantation research integrates issues from Stem cell and Bone marrow.
Her Cytotoxic T cell study combines topics from a wide range of disciplines, such as Epstein–Barr virus and CD8.
The various areas that Catherine M. Bollard examines in her Immunotherapy study include Cancer research and Lymphoma.
She interconnects Cytokine and Cord blood in the investigation of issues within Immune system.
She most often published in these fields:
- Immunology (67.66%)
- Cytotoxic T cell (34.80%)
- Immunotherapy (33.39%)
What were the highlights of her more recent work (between 2017-2021)?
- Immunotherapy (33.39%)
- Immunology (67.66%)
- Immune system (23.55%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Immunotherapy, Immunology, Immune system, T cell and Cancer research.
Her research integrates issues of Cytotoxic T cell and Antigen in her study of Immunotherapy.
Catherine M. Bollard performs integrative study on Immunology and BK virus.
Her Immune system research is multidisciplinary, incorporating perspectives in Antibody, Antibody-dependent cell-mediated cytotoxicity and Cord blood.
Catherine M. Bollard has included themes like Hematopoietic stem cell transplantation, Oncology, CD8, Internal medicine and Cell therapy in her T cell study.
Her study in Cancer research is interdisciplinary in nature, drawing from both Ex vivo, Receptor and Cytokine.
Between 2017 and 2021, her most popular works were:
- Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy (87 citations)
- Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells (87 citations)
- Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells (87 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Immune system
Catherine M. Bollard mostly deals with Immunotherapy, Immune system, Cytotoxic T cell, Immunology and Cancer research.
Her Immune system study combines topics in areas such as Stem cell and Cord blood.
Her work deals with themes such as PLGA, CD8, Cytokine and Pharmacology, which intersect with Cytotoxic T cell.
Her study in T cell, Virus and Adoptive cell transfer falls within the category of Immunology.
Her T cell study incorporates themes from Hematopoietic stem cell transplantation, Primary immunodeficiency and Cell therapy.
Her Cancer research study also includes
- Tumor microenvironment together with Receptor,
- Antigen which intersects with area such as Ex vivo.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
